Clinical Trial Update: Clinical Study of Ningmitai Capsule on Promoting the Passage of Residual Fragments After Ureteroscopic Lithotripsy [Phase 4]

View source ↗

Summary

Phase 4 clinical study evaluating Ningmitai Capsule for promoting passage of residual fragments after ureteroscopic lithotripsy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ureteral Calculi

Drugs mentioned

• Ningmitai Capsule

Snippet

Sponsor: Xintian Pharmaceutical | Conditions: Ureteral Calculi | Phase 4 | Status: COMPLETED